{"nct_id":"NCT03573323","title":"A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2018-11-09","start_date_type":"ACTUAL","primary_completion_date":"2019-07-15","primary_completion_date_type":"ACTUAL","completion_date":"2020-01-08","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["LLY"]}